Supports energy metabolism as a cofactor
According to a November 2025 report by Cubemarket S.R.O.s Fact.MR research resource, protein-based ready-to-drink beverages are widely used in the USA for weight management, satiety enhancement, and muscle maintenance where immediate convenience, nutritional reliability, and effectiveness remain essential for consumer compliance and program adherence. The Fact.MR report also touched on the calorie-reduction side of the category, noting that, [The] low-calorie claim segment is expected to represent 52% of USA weight management beverages demand for 2025
The lean-mass loss is broadly comparable to semaglutide
FASEB J 30, 12843
Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals A pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with type 2 diabetes and chronic kidney disease
PMID 15214618
